Genitourinary videos

Round-ups, expert picks and interviews, newest first.

October 2025

Day 4 round-up: IMvigor011, DYNAMIC-III, FORTITUDE-101
Dr. Gil Morgan. Daily round-up. ESMO 2025. Day 4.
Day 3 round-up: the top five trials
Dr. Gil Morgan. Daily round-up. ESMO 2025. Day 3.
Day 2 round-up: five practice-changing trials
Dr. Gil Morgan. Daily round-up. ESMO 2025. Day 2.
Prostate cancer: EMBARK, CAPItello-281, PETRANHA
Dr. Gil Morgan. Expert pick. ESMO 2025.
Radioligand therapy in prostate cancer
Dr. Silke Gillessen. ESMO 2025. Interview.
Kidney cancer: RAMPART, O3A and OPTIC
Dr. Brian Rini. Expert pick. ESMO 2025.
OPTIC RCC: a biomarker-selected combination
Dr. Brian Rini. Expert pick. ESMO 2025.
DISCUS (LBA 109): three or six cycles before avelumab
Dr. Enrique Grande. Expert pick. ESMO 2025.
IMvigor011: ctDNA after cystectomy
Dr. Tom Powles. Expert pick. ESMO 2025.

June 2025

Prostate cancer at ASCO 2025
Dr. Natalia Gandur. Expert pick. ASCO 2025. In Spanish.
CBM588 with nivolumab and ipilimumab in kidney cancer
Dr. Miguel Zugman. ASCO 2025. Interview.
CheckMate 214: the nine-year final results
Dr. Brian Rini. Interview. ASCO 2025.
Metastatic castration-resistant prostate cancer at ASCO 2025
Dr. Natalia Gandur. Expert pick. ASCO 2025. In Spanish.
KIM-1 in renal cell carcinoma
Dr. Marc Machaalani. ASCO 2025. Interview.
Bladder cancer: antibody-drug conjugates, today and tomorrow
Dr. Brian Rini. Interview. ASCO 2025.

The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.

Email address

Your role

Your country

How we use your details

Genitourinary videos

October 2025

June 2025

The week in oncology, in your inbox